Holly Wong

Holly Wong, PharmD, currently serves as a Senior Medical Science Liaison at BioCryst Pharmaceuticals, Inc. since September 2023. Prior experience includes roles in Global Medical Affairs for Rare Diseases at Sanofi from July 2022 to September 2023 and as a Medical Communications Associate at Johnson & Johnson from July 2021 to June 2022. Holly Wong has also contributed to patient-informed development and health value translation at Sanofi for a brief period in mid-2021 and worked as a Clinical Operations Associate at Alnylam Pharmaceuticals from September 2019 to May 2021. Additional experience includes internships at Shriners Hospitals for Children from April 2018 to December 2019 and CVS Health from January 2018 to April 2019. Holly Wong completed a Doctor of Pharmacy (PharmD) degree at Northeastern University.